{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:16:41Z","timestamp":1760080601424,"version":"3.44.0"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2022,1,31]]},"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Sialorrhoea is a debilitating symptom in neurological disease and there is a growing literature for the use of intrasalivary gland Botulinum Toxin (botox) injections in its management. However, provision of intrasalivary gland botox remains inconsistent and sialorrhoea is often poorly controlled in motor neuron disease (MND).<\/jats:p>\n                  <jats:p>Sialorrhoea in association with bulbar dysfunction can cause intolerance of non-invasive ventilation (NIV) and respiratory infection, so its treatment is critical within a home ventilation service (HVS).<\/jats:p>\n                  <jats:p>This treatment can also be used to enable tracheostomy cuff deflation to facilitate weaning from ventilation. We report on the outcomes of intrasalivary gland botox in our HVS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In 2015, we set up an intrasalivary gland botox service for patients under our HVS. Under ultrasound guidance, we injected submandibular gland<\/jats:p>\n                  <jats:p>(SMG), parotid gland (PG) or both.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>109 intrasalivary gland botox procedures were performed in 72 patients. Diagnostic groups included MND 32<\/jats:p>\n                  <jats:p>Cerebral Palsy 8 and Weaning 14. Glands injected were, SMG (6%), PG (47%) and both (47%). The majority (84%) received the Dysport preparation with mean dose 273 units. 94% were ultrasound guided. 81% of injections resulted in a positive treatment effect, with 47% patients requesting repeat injections. Complications were angioedema (0.9%) and worsening dysphagia (3.7% following SMG injection). Mean survival following treatment was 40 months with 53% patients still alive.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Intrasalivary gland botox appears effective across a range of neurological conditions requiring long-term NIV with few complications. Dysphagia may be an important complication of SMG injection. A randomised controlled trial may help establish the evidence base.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2021-001188","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T12:07:33Z","timestamp":1645445253000},"page":"e001188","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Developing an intrasalivary gland botox service for patients receiving long-term non-invasive ventilation at home: a single-centre experience"],"prefix":"10.1136","volume":"9","author":[{"given":"Jessica","family":"Harbottle","sequence":"first","affiliation":[{"name":"School of Medical Education, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Carlin","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Payne-Doris","sequence":"additional","affiliation":[{"name":"North East Assisted Ventilation Service, Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary M I","family":"Tedd","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"de Soyza","sequence":"additional","affiliation":[{"name":"Population Health Science Institutes, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Messer","sequence":"additional","affiliation":[{"name":"North East Assisted Ventilation Service, Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"2025083110450296000_9.1.e001188.1","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez LM , Taylor MK . Chapter 2 - Salivary Gland Anatomy and Physiology. In: Granger DA , Taylor MK , eds. Salivary bioscience. Springer, 2020: 11\u201320.","DOI":"10.1007\/978-3-030-35784-9_2"},{"key":"2025083110450296000_9.1.e001188.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-011-1570-y"},{"key":"2025083110450296000_9.1.e001188.3","doi-asserted-by":"crossref","unstructured":"Johnson J , Evatt ML , Chaudhuri KR . Sialorrhoea in Parkinson\u2019s disease. In: Ray Chaudhuri K , Tolosa E , Schapira AHV , eds. Non-motor symptoms of Parkinson\u2019s disease. 2nd ed. USA: Oxford University Press, 2014.","DOI":"10.1093\/med\/9780199684243.003.0021"},{"key":"2025083110450296000_9.1.e001188.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03501.x"},{"key":"2025083110450296000_9.1.e001188.5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/21678421.2013.790452","article-title":"Management of sialorrhoea in motor neuron disease: a survey of current UK practice","volume":"14","author":"Hobson","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025083110450296000_9.1.e001188.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208919"},{"key":"2025083110450296000_9.1.e001188.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2010.03765.x"},{"key":"2025083110450296000_9.1.e001188.8","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00513","article-title":"Efficacy of botulinum toxin for treating sialorrhea in neuromuscular conditions","volume":"11","author":"Singh","year":"2020","journal-title":"Front Neurol"},{"key":"2025083110450296000_9.1.e001188.9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5535\/arm.2013.37.1.96","article-title":"Evaluation of salivary aspiration in brain-injured patients with tracheostomy","volume":"37","author":"Kang","year":"2013","journal-title":"Ann Rehabil Med"},{"key":"2025083110450296000_9.1.e001188.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70326-4"},{"key":"2025083110450296000_9.1.e001188.11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jsmc.2020.08.004","article-title":"Noninvasive ventilation in amyotrophic lateral sclerosis","volume":"15","author":"Cooksey","year":"2020","journal-title":"Sleep Med Clin"},{"key":"2025083110450296000_9.1.e001188.12","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02103"},{"key":"2025083110450296000_9.1.e001188.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21678421.2016.1221433","article-title":"A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis","volume":"18","author":"McGeachan","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025083110450296000_9.1.e001188.14","unstructured":"Nice.org.uk, 2013. Available: https:\/\/www.nice.org.uk\/advice\/esuom15\/resources\/hypersalivation-oral-glycopyrronium-bromide-pdf-54116458942789573 [Accessed 31 Oct 2021]."},{"key":"2025083110450296000_9.1.e001188.15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ene.15083","article-title":"Efficacy and safety of botulinum toxin for treating sialorrhea: a systematic review and meta-analysis","volume":"29","author":"Yu","year":"2022","journal-title":"Eur J Neurol"},{"key":"2025083110450296000_9.1.e001188.16","unstructured":"Nice.org.uk, 2019. Available: https:\/\/www.nice.org.uk\/guidance\/ta605\/resources\/xeomin-botulinum-neurotoxin-type-a-for-treating-chronic-sialorrhoea-pdf-82608898003909 [Accessed 31 Oct 2021]."},{"key":"2025083110450296000_9.1.e001188.17","unstructured":"Motor neurone disease: assessment and management. Available: https:\/\/www.nice.org.uk\/guidance\/ng42\/chapter\/Recommendations-for-research#4-saliva [Accessed 18 Jan 2022]."},{"key":"2025083110450296000_9.1.e001188.18","first-page":"CD006981","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis","volume":"5","author":"Young","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083110450296000_9.1.e001188.19","doi-asserted-by":"crossref","first-page":"e1982","DOI":"10.1212\/WNL.0000000000007368","article-title":"SIAXI","volume":"92","author":"Jost","year":"2019","journal-title":"Neurology"},{"key":"2025083110450296000_9.1.e001188.20","doi-asserted-by":"crossref","DOI":"10.3390\/children8121089","article-title":"Botulinum toxin injections for treatment of drooling in children with cerebral palsy: a systematic review and meta-analysis","volume":"8","author":"Hung","year":"2021","journal-title":"Children"},{"key":"2025083110450296000_9.1.e001188.21","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23473"},{"key":"2025083110450296000_9.1.e001188.22","doi-asserted-by":"publisher","DOI":"10.3109\/00016357.2010.545035"},{"key":"2025083110450296000_9.1.e001188.23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00702-019-02044-6","article-title":"Incobotulinumtoxina for hypersalivation in patients with amyotrophic lateral sclerosis: an open-label single-centre study","volume":"126","author":"Paracka","year":"2019","journal-title":"J Neural Transm"},{"key":"2025083110450296000_9.1.e001188.24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00455-014-9535-8","article-title":"The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis\/motor neurone disease: a systematic review","volume":"29","author":"Squires","year":"2014","journal-title":"Dysphagia"},{"key":"2025083110450296000_9.1.e001188.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2003.10.012"},{"key":"2025083110450296000_9.1.e001188.26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/21678421.2012.735238","article-title":"Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: a study in a large French cohort","volume":"14","author":"Abdelnour-Mallet","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025083110450296000_9.1.e001188.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00210-5"},{"key":"2025083110450296000_9.1.e001188.28","doi-asserted-by":"publisher","DOI":"10.3109\/17482960902919360"},{"key":"2025083110450296000_9.1.e001188.29","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.07005"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2021-001188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:45:17Z","timestamp":1756662317000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2021-001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2,21]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/bmjresp-2021-001188"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2021-001188","relation":{},"ISSN":["2052-4439"],"issn-type":[{"type":"electronic","value":"2052-4439"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}